Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 3.55 is in line with its 5-year average of 3.89, near the low end of its 5-year range (2.37–6.65).
48.85% above its 12-month average of 2.38.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
3.55
EARNINGS PER SHARE (EPS) AVG TTM
2.38
EARNINGS PER SHARE (EPS) AVG 3Y
3.54
EARNINGS PER SHARE (EPS) AVG 5Y
3.89
EARNINGS PER SHARE (EPS) AVG 10Y
3.86
EARNINGS PER SHARE (EPS) AVG 15Y
2.93
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+48.85%
CURRENT VS 3Y AVG
+0.35%
CURRENT VS 5Y AVG
-8.82%
CURRENT VS 10Y AVG
-8.03%
CURRENT VS 15Y AVG
+20.98%
CURRENT VS 20Y AVG
N/A
Market Cap
$367.26B
Earnings Per Share (EPS)
1.25
TTM Avg
7.03
3Y Avg
4.98
5Y Avg
4.65
Market Cap
$366.38B
Earnings Per Share (EPS)
15.55
TTM Avg
14.44
3Y Avg
18.63
5Y Avg
18.19
Market Cap
$345.25B
Earnings Per Share (EPS)
2.55
TTM Avg
1.99
3Y Avg
2.05
5Y Avg
2.14
Market Cap
$248.49B
Earnings Per Share (EPS)
6.66
TTM Avg
5.57
3Y Avg
4.27
5Y Avg
3.27
Market Cap
$651.09B
Earnings Per Share (EPS)
8.63
TTM Avg
8.43
3Y Avg
9.39
5Y Avg
8.52
Market Cap
$224.73B
Earnings Per Share (EPS)
18.59
TTM Avg
17.17
3Y Avg
16.90
5Y Avg
17.22
Market Cap
$213.83B
Earnings Per Share (EPS)
16.09
TTM Avg
10.97
3Y Avg
11.67
5Y Avg
11.57
Market Cap
$201.12B
Earnings Per Share (EPS)
4.06
TTM Avg
3.38
3Y Avg
2.82
5Y Avg
2.39
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $440.81B | 3.55 | 2.38 | 3.54 | 3.89 |
| Merck & Co., Inc. (MRK)vs › | $367.26B | 1.25 | 7.03 | 4.98 | 4.65 |
| UnitedHealth Group Incorporated (UNH)vs › | $366.38B | 15.55 | 14.44 | 18.63 | 18.19 |
| Roche Holding AG (RHHBY)vs › | $345.25B | 2.55 | 1.99 | 2.05 | 2.14 |
| AstraZeneca PLC (AZN)vs › | $248.49B | 6.66 | 5.57 | 4.27 | 3.27 |
| Johnson & Johnson (JNJ)vs › | $651.09B | 8.63 | 8.43 | 9.39 | 8.52 |
| Thermo Fisher Scientific Inc. (TMO)vs › | $224.73B | 18.59 | 17.17 | 16.90 | 17.22 |
| Amgen Inc. (AMGN)vs › | $213.83B | 16.09 | 10.97 | 11.67 | 11.57 |
| Novo Nordisk A/S (NVO)vs › | $201.12B | 4.06 | 3.38 | 2.82 | 2.39 |
| Abbott Laboratories (ABT)vs › | $182.92B | 3.11 | 5.71 | 4.66 | 4.19 |
Trailing EPS (TTM)
$3.55
Forward EPS (Est.)
$14.03
P/E Ratio
72.3
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 2.37 |
| 2024-12-31 | 2.40 |
| 2023-12-31 | 2.73 |
| 2022-12-31 | 6.65 |
| 2021-12-31 | 6.48 |
| 2020-12-31 | 2.73 |
| 2019-12-31 | 5.30 |
| 2018-12-31 | 3.69 |
| 2017-12-31 | 3.31 |
| 2016-12-31 | 3.65 |
| 2015-12-31 | 3.15 |
| 2014-12-31 | 1.11 |
| 2013-12-31 | 2.58 |
| 2012-12-31 | 3.35 |
| 2011-12-31 | 2.12 |
| 2010-12-31 | 2.59 |
| 2009-12-31 | 2.87 |
Reported annual fiscal-period values; no daily interpolation.
